Dr. Don Vinh.

Dr. Donald Vinh is part of a research group that received $2.7 million dollars from the The Government of Canada, through its COVID-19 Immunity Task Force (CITF) in support of this study which is aimed at identifying the factors putting each person at risk of developing severe COVID-19 symptoms and medical complications that may lead to a fatal disease. The research team is multi-institutional and multi-disciplinary, involving the Research Institute of the McGill University Health Centre (RI-MUHC), Université de Montréal, Institut Universitaire de Gériatrie de Montréal (IUGM) and its Research Center (CRIUGM), Douglas Research Centre, McGill University’s Department of Psychiatry, and Concordia University’s Department of Psychology. The study is being carried out in partnership with two health networks (CIUSSS Centre Sud and CIUSSS de l’Ouest-de-l’Île-de-Montréal).

Our study brings together immunological, biochemical, and psychosocial expertise to identify key factors that determine severe COVID-19 symptoms and complications in the elderly. If we can identify elderly people at greater risk of developing medical complications from COVID-19, it can guide better infection control measures and prioritize medical care to increase the chance that these people will have better treatment outcomes.  The hope is to help avoid unnecessary hospitalization and in so doing, reduce the use of health care resources. —Dr. Don Vinh

Read more:


Latest News


Research groups